HISTOCHEMICAL DISTRIBUTION OF CA-125 AS A PROGNOSTIC INDICATOR IN PATIENTS WITH SEROUS OVARIAN-CANCER

被引:3
|
作者
BICHEL, P
JAKOBSEN, A
ORNTOFT, TF
机构
[1] AARHUS UNIV, AARHUS KOMMUNE HOSP, INST PATHOL, DEPT CLIN CHEM, DK-8000 AARHUS, DENMARK
[2] VEJLE CENT HOSP, INST PATHOL, AARHUS, DENMARK
[3] DANISH CANC SOC, DEPT EXPTL CLIN ONCOL, AARHUS, DENMARK
关键词
CA-125; HISTOCHEMICAL DISTRIBUTION; OVARY CARCINOMA; PROGNOSIS;
D O I
10.1111/j.1525-1438.1991.tb00040.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study comprises 66 patients with stage Ill and IV serous ovarian carcinoma While the percentage of CA-125 positive cells and the staining intensity showed no correlation to patient survival, the pattern of CA-125 distribution, membranous versus cytoplasmic, was significantly correlated to survival. In accordance with other observations on switching of the antigen reaction f rom membrane to cytoplasm with increasing grade of atypia or malignancy, patients with membrane positive CA-125 tumors had a significantly better prognosis than did patients with CA-125 in the cytoplasm. Furthermore, there was excellent agreement between, on the one hand, the binding pattern of CA-125 and, on the other, the ploidy of the tumor cells and the HGI histopathologic grading index, both previously shown to be of prognostic significance.
引用
下载
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [11] CA-125 IN THE FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER
    KOELBL, H
    SCHIEDER, K
    NEUNTEUFEL, W
    BIEGLMAYER, C
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1988, 27 (04): : 335 - 342
  • [12] CA-125 - MARKER OF OVARIAN-CANCER OR ASCITES
    BERGMANN, JF
    BIDART, JM
    GEORGE, M
    BEAUGRAND, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1987, 11 (2BIS): : A215 - A215
  • [13] SCREENING FOR OVARIAN-CANCER BY CA-125 MEASUREMENT
    CRUICKSHANK, DJ
    LANCET, 1988, 1 (8584): : 540 - 541
  • [14] CA-125 IN THE FOLLOW-UP OF PATIENTS WITH OVARIAN-CANCER
    HALILA, H
    LEHTOVIRTA, P
    STENMAN, UH
    SEPPALA, M
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1988, 67 (01) : 53 - 58
  • [15] MARKERS SUPPLEMENTING CA-125 IN OVARIAN-CANCER
    STENMAN, UH
    ALFTHAN, H
    VARTIAINEN, J
    LEHTOVIRTA, P
    ANNALS OF MEDICINE, 1995, 27 (01) : 115 - 120
  • [16] THE PROGNOSTIC VALUE OF POST CHEMOTHERAPY SERUM CA-125 IN EPITHELIAL OVARIAN-CANCER
    TEELING, M
    MCGING, P
    CARNEY, DN
    IRISH JOURNAL OF MEDICAL SCIENCE, 1989, 158 (03) : 59 - 62
  • [17] THE OVARIAN-CANCER ASSOCIATED ANTIGEN CA-125 IN PATIENTS WITH PLEURAL EFFUSIONS
    LINDGREN, J
    KUUSELA, P
    HELLSTROM, PE
    PETTERSSON, T
    KLOCKARS, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04): : 737 - 739
  • [18] CLINICAL RELEVANCE OF THE CA-125 ASSAY IN MONITORING OF OVARIAN-CANCER PATIENTS
    HISING, C
    ANJEGARD, IM
    EINHORN, N
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (02): : 111 - 114
  • [19] TUMOR-MARKER CA-125 IN OVARIAN-CANCER
    SEVELDA, P
    WIENER KLINISCHE WOCHENSCHRIFT, 1987, 99 (14) : 512 - 513
  • [20] TUMOR-ASSOCIATED ANTIGEN CA-125 IN PATIENTS WITH OVARIAN-CANCER
    HEINONEN, PK
    TONTTI, K
    KOIVULA, T
    PYSTYNEN, P
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1985, 92 (05): : 528 - 531